Evidence for Dopaminergic Involvement in Endogenous Modulation of Pain Relief

Overview

Journal Elife

Specialty Biology

Date 2023 Feb 1

PMID 36722857

Authors

Simon Desch

Petra Schweinhardt

Ben Seymour

Herta Flor

Susanne Becker

Affiliations

Soon will be listed here.

Abstract

Relief of ongoing pain is a potent motivator of behavior, directing actions to escape from or reduce potentially harmful stimuli. Whereas endogenous modulation of pain events is well characterized, relatively little is known about the modulation of pain relief and its corresponding neurochemical basis. Here, we studied pain modulation during a probabilistic relief-seeking task (a 'wheel of fortune' gambling task), in which people actively or passively received reduction of a tonic thermal pain stimulus. We found that relief perception was enhanced by active decisions and unpredictability, and greater in high novelty-seeking trait individuals, consistent with a model in which relief is tuned by its informational content. We then probed the roles of dopaminergic and opioidergic signaling, both of which are implicated in relief processing, by embedding the task in a double-blinded cross-over design with administration of the dopamine precursor levodopa and the opioid receptor antagonist naltrexone. We found that levodopa enhanced each of these information-specific aspects of relief modulation but no significant effects of the opioidergic manipulation. These results show that dopaminergic signaling has a key role in modulating the perception of pain relief to optimize motivation and behavior.

Citing Articles

Dopamine has no direct causal role in the formation of treatment expectations and placebo analgesia in humans.

Kunkel A, Asan L, Kruger I, Erfurt C, Ruhnau L, Caliskan E PLoS Biol. 2024; 22(9):e3002772.

PMID: 39316644 PMC: 11421806. DOI: 10.1371/journal.pbio.3002772.

Reward processes in extinction learning and applications to exposure therapy.

Rosenberg B, Barnes-Horowitz N, Zbozinek T, Craske M J Anxiety Disord. 2024; 106:102911.

PMID: 39128178 PMC: 11384290. DOI: 10.1016/j.janxdis.2024.102911.

Alcohol use and the pain system.

Vigorito M, Chang S Adv Drug Alcohol Res. 2024; 4:12005.

PMID: 38389900 PMC: 10880763. DOI: 10.3389/adar.2024.12005.

How Instructions, Learning, and Expectations Shape Pain and Neurobiological Responses.

Atlas L Annu Rev Neurosci. 2023; 46:167-189.

PMID: 36917820 PMC: 11793868. DOI: 10.1146/annurev-neuro-101822-122427.

Evidence for dopaminergic involvement in endogenous modulation of pain relief.

Desch S, Schweinhardt P, Seymour B, Flor H, Becker S Elife. 2023; 12.

PMID: 36722857 PMC: 9988263. DOI: 10.7554/eLife.81436.

References

Langdon A, Sharpe M, Schoenbaum G, Niv Y . Model-based predictions for dopamine. Curr Opin Neurobiol. 2017; 49:1-7. PMC: 6034703. DOI: 10.1016/j.conb.2017.10.006. View

Gomtsian L, Bannister K, Eyde N, Robles D, Dickenson A, Porreca F . Morphine effects within the rodent anterior cingulate cortex and rostral ventromedial medulla reveal separable modulation of affective and sensory qualities of acute or chronic pain. Pain. 2018; 159(12):2512-2521. PMC: 6320264. DOI: 10.1097/j.pain.0000000000001355. View

Kleinbohl D, Holzl R, Moltner A, Rommel C, Weber C, Osswald P . Psychophysical measures of sensitization to tonic heat discriminate chronic pain patients. Pain. 1999; 81(1-2):35-43. DOI: 10.1016/s0304-3959(98)00266-8. View

Santesso D, Evins A, Frank M, Schetter E, Bogdan R, Pizzagalli D . Single dose of a dopamine agonist impairs reinforcement learning in humans: evidence from event-related potentials and computational modeling of striatal-cortical function. Hum Brain Mapp. 2008; 30(7):1963-76. PMC: 3034238. DOI: 10.1002/hbm.20642. View

Vaillancourt D, Schonfeld D, Kwak Y, Bohnen N, Seidler R . Dopamine overdose hypothesis: evidence and clinical implications. Mov Disord. 2013; 28(14):1920-9. PMC: 3859825. DOI: 10.1002/mds.25687. View

Benedetti F . The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia. Pain. 1996; 64(3):535-543. DOI: 10.1016/0304-3959(95)00179-4. View

Eippert F, Bingel U, Schoell E, Yacubian J, Klinger R, Lorenz J . Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron. 2009; 63(4):533-43. DOI: 10.1016/j.neuron.2009.07.014. View

Navratilova E, Atcherley C, Porreca F . Brain Circuits Encoding Reward from Pain Relief. Trends Neurosci. 2015; 38(11):741-750. PMC: 4752429. DOI: 10.1016/j.tins.2015.09.003. View

Daw N, Doya K . The computational neurobiology of learning and reward. Curr Opin Neurobiol. 2006; 16(2):199-204. DOI: 10.1016/j.conb.2006.03.006. View

10.

Sirucek L, Price R, Gandhi W, Hoeppli M, Fahey E, Qu A . Endogenous opioids contribute to the feeling of pain relief in humans. Pain. 2021; 162(12):2821-2831. PMC: 8600541. DOI: 10.1097/j.pain.0000000000002285. View

11.

Leknes S, Brooks J, Wiech K, Tracey I . Pain relief as an opponent process: a psychophysical investigation. Eur J Neurosci. 2008; 28(4):794-801. DOI: 10.1111/j.1460-9568.2008.06380.x. View

12.

Fontanesi L, Gluth S, Spektor M, Rieskamp J . A reinforcement learning diffusion decision model for value-based decisions. Psychon Bull Rev. 2019; 26(4):1099-1121. PMC: 6820465. DOI: 10.3758/s13423-018-1554-2. View

13.

Xie J, Qu C, Patwardhan A, Ossipov M, Navratilova E, Becerra L . Activation of mesocorticolimbic reward circuits for assessment of relief of ongoing pain: a potential biomarker of efficacy. Pain. 2014; 155(8):1659-1666. PMC: 4118589. DOI: 10.1016/j.pain.2014.05.018. View

14.

Rinne U, BIRKET-SMITH E, Dupont E, Hansen E, Hyyppa M, Marttila R . Levodopa alone and in combination with a peripheral decarboxylase inhibitor benserazide (Madopar) in the treatment of Parkinson's disease: A controlled clinical trial. J Neurol. 1975; 211(1):1-9. DOI: 10.1007/BF00312459. View

15.

Glimcher P . Understanding dopamine and reinforcement learning: the dopamine reward prediction error hypothesis. Proc Natl Acad Sci U S A. 2011; 108 Suppl 3:15647-54. PMC: 3176615. DOI: 10.1073/pnas.1014269108. View

16.

Raynor K, Kong H, Chen Y, Yasuda K, Yu L, Bell G . Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. Mol Pharmacol. 1994; 45(2):330-4. View

17.

Desch S, Schweinhardt P, Seymour B, Flor H, Becker S . Evidence for dopaminergic involvement in endogenous modulation of pain relief. Elife. 2023; 12. PMC: 9988263. DOI: 10.7554/eLife.81436. View

18.

Breitenstein C, Korsukewitz C, Floel A, Kretzschmar T, Diederich K, Knecht S . Tonic dopaminergic stimulation impairs associative learning in healthy subjects. Neuropsychopharmacology. 2006; 31(11):2552-64. DOI: 10.1038/sj.npp.1301167. View

19.

Luce R . On the possible psychophysical laws. Psychol Rev. 1959; 66(2):81-95. DOI: 10.1037/h0043178. View

20.

Nyholm D, Lewander T, Gomes-Trolin C, Backstrom T, Panagiotidis G, Ehrnebo M . Pharmacokinetics of levodopa/carbidopa microtablets versus levodopa/benserazide and levodopa/carbidopa in healthy volunteers. Clin Neuropharmacol. 2012; 35(3):111-7. DOI: 10.1097/WNF.0b013e31825645d1. View